![]() IN8Bio IN8Bio (formerly known as Innatus Therapeutics, Incysus Therapeutics) is a clinical-stage biopharmaceutical company focused on the development of gamma-delta T cell therapies for the treatment of cancer. | ![]() FORMA Therapeutics FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines. | ![]() Aura Biosciences Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology. | Revolution Medicines Revolution Medicines (RevMed) is a clinical-stage oncology company that develops therapies for cancer patients. | ||
Founding Date | Founding Date 2016 | Founding Date 2008 | Founding Date 2009 | Founding Date 2014 | Founding Date 2002 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations New York, US HQ Birmingham, US | Locations Watertown, US HQ | Locations Cambridge, US HQ | Locations Redwood City, US HQ Redwood City, US | Locations TW HQ San Diego, US |
Employees | Employees 13 | Employees 77 | Employees 42 | Employees 37854% increase | Employees 124 |
Valuation ($) | Valuation ($) 19.9 m | Valuation ($) 998.7 m | Valuation ($) 544.2 m | Valuation ($) 8.4 b | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($19.4m) (FY, 2025) | Net income ($173m) (FY, 2021) | Net income ($106.2m) (FY, 2025) | Net income ($1.1b) (FY, 2025) | Net income (NT$2.5b) (FY, 2024) |
Funding | |||||
Total funding raised | Total funding raised $ 35m | Total funding raised $ 142.5m | Total funding raised $ 213.9m | Total funding raised $ 226m | Total funding raised N/A |

FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines.
View company
Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology.
View companyRevolution Medicines (RevMed) is a clinical-stage oncology company that develops therapies for cancer patients.
View company
OBI Pharma (台灣浩鼎) is a bio-pharma company focused on cancer therapeutics.
View company